tyrosine has been researched along with orantinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
André, I; Boonyarat, C; Grierson, DS; Kammasud, N; Saiki, I; Sakurai, H; Sanphanya, K; Tsunoda, S; Utsintong, M; Vajragupta, O | 1 |
1 other study(ies) available for tyrosine and orantinib
Article | Year |
---|---|
5-Substituted pyrido[2,3-d]pyrimidine, an inhibitor against three receptor tyrosine kinases.
Topics: Cell Proliferation; Cells, Cultured; Chemistry, Pharmaceutical; Drug Design; Endothelium, Vascular; Enzyme Inhibitors; Fibroblast Growth Factor 2; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Oxindoles; Phosphorylation; Propionates; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; Receptor Protein-Tyrosine Kinases; Tyrosine | 2009 |